Filing Details

Accession Number:
0001209191-18-023804
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-04 17:18:58
Reporting Period:
2018-04-02
Accepted Time:
2018-04-04 17:18:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Eiger Biopharmaceuticals Inc. EIGR Biological Products, (No Disgnostic Substances) (2836) 361004130
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670138 Joanne Quan 350 Cambridge Ave, Suite 350
Palo Alto CA 94306
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-02 4,000 $2.06 4,000 No 4 M Direct
Common Stock Disposition 2018-04-02 4,000 $10.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-04-02 4,000 $0.00 4,000 $2.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,256 2025-09-22 No 4 M Direct
Footnotes
  1. 25% of the option vested on April 14, 2016 and the remaining shares vest in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date.